Blueprint Medicines Corporation (BPMC) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 144/A - Report of proposed sale of securities: [Amend]

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance

Blueprint Medicines Reports Third Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year...

Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024

Blueprint Medicines to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024 PR...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Blueprint Medicines to Present at Upcoming Investor Conferences

Blueprint Medicines to Present at Upcoming Investor Conferences PR Newswire CAMBRIDGE, Mass., Sept. 10, 2024...

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities